273 related articles for article (PubMed ID: 4652424)
1. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
[No Abstract] [Full Text] [Related]
2. [Interactions of reserve antitubercular agents in combined administration].
Korotaev GA; Kozulitsyna TM
Probl Tuberk; 1978 Sep; (9):56-60. PubMed ID: 704600
[No Abstract] [Full Text] [Related]
3. [Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
Tynystanova RI; Kozlova NV
Probl Tuberk; 1984 Jul; (7):59-63. PubMed ID: 6483843
[No Abstract] [Full Text] [Related]
4. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
[No Abstract] [Full Text] [Related]
5. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
6. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.
Sriyabhaya N; Jittinandana A; Kecharanantana P
J Med Assoc Thai; 1974 Nov; 57(11):551-7. PubMed ID: 4452812
[No Abstract] [Full Text] [Related]
8. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
Masztalerz J
Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
[No Abstract] [Full Text] [Related]
9. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
Kotowska M; Zelski S
Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230
[No Abstract] [Full Text] [Related]
10. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Oka S; Sasaki M; Kobayashi T; Matsuda T
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
[No Abstract] [Full Text] [Related]
11. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Girling DJ
Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
[No Abstract] [Full Text] [Related]
12. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
Anastasatu C; Sibila S
Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
[No Abstract] [Full Text] [Related]
13. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
Masztalerz J
Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
[No Abstract] [Full Text] [Related]
14. [Experimental study of schedules for intermittent administration of rifampicin and ethambutol].
Kozulitsyna TI; Petrov IV
Probl Tuberk; 1976 May; (5):72-5. PubMed ID: 951412
[No Abstract] [Full Text] [Related]
15. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
16. [A controlled comparison of daily and intermittent administration of rifampicin in retreatment of pulmonary tuberculosis].
Yamamoto K; Aizawa H; Sasaoka M; Kawamori Y; Kakuno J
Kekkaku; 1972 Dec; 47(12):467-73. PubMed ID: 4652425
[No Abstract] [Full Text] [Related]
17. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
[No Abstract] [Full Text] [Related]
18. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
Gomi J; Aoyagi T
Scand J Respir Dis Suppl; 1973; 84():145-52. PubMed ID: 4522070
[No Abstract] [Full Text] [Related]
19. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
Semenova OV
Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
[TBL] [Abstract][Full Text] [Related]
20. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
